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Fig.1 Comparison between Fluka MC simulation (red line), 
dose distribution evaluated with CERR using Double 
Gaussian model (green line) and dose predicted by 
standalone computational model (blue line) for a proton 
initial beam energy of 60MeV, initial σ  of 0.4cm, at a 
normalized depth 0.9 (assuming Bragg peak position at 1) 
 
The preliminary results show that the model is able to 
predict dose with better accuracy than DGA. 
So, this model could be a step forward in lateral dose 
prediction for current TPS and as a future application, a 
useful tool for online dose-evaluation and adaptive 
planning; next step will be the implementation of different 
media and geometries. 
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Purpose: To define the clinical protocol for Head and Neck 
(H&N) patients treated with Proton Pencil Beam Scanning 
(PBS) at Paul Scherrer Institute (PSI, Villigen CH) with 
Simultaneous Integrated Boost (SIB). The focus was mainly to 
define the optimization parameters and the normalization 
procedure to obtain a steep gradient between the elective 
and the boost volume, in order to reduce over-dosage in the 
fall off area of the boost.  
Material and Methods: 7 patients, treated at PSI for different 
H&N carcinomas, were selected for this study. They were all 
originally treated with two sequential series at 2GyRBE;  the 
1st one up to 54GyRBE to the elective Planning Target Volume 
(PTV1), followed by a second series up to 72GyRBE for the 
boost target volume (PTV2). In this study, all have been re-
planned using a SIB regimen of 1.8GyRBE (up to 54GyRBE) to 
PTV1 and 2.36GyRBE (up to 70.8GyRBE) to PTV2 for a total of 
30 fractions. Dose constraints to the OARs were kept as for 
the sequential approach [1]. All plans were designed on the 
PSIPlan Treatment Planning System using Intensity Modulated 
Proton Therapy (IMPT) with non-coplanar fields. The 
prescription dose of 100% corresponded to the average dose 
to PTV1, while the dose to PTV2 was optimized prescribing a 
boosting factor based on the ratio of the two different 
prescribed dose levels (i.e. 54GyRBE and 70.8 GyRBE). 
Depending on the ratio of the PTV1 and PTV2 volumes the 
boosting factor was prescribed to PTV2 or to a smaller 
structure (GTV or PTV2-3mm). To guarantee dose 
homogeneity in the dose gradient region between PTV1 and 
PTV2, the optimized SIB plans were normalized such that 
54GyRBE corresponded to the average dose to [PTV1-(Boost 
volume+3mm)]. This avoided over-dosages close to PTV2 
being compensated by under-dosages at the PTV1 margin.  
Results:  The choice of the boosted volume, the boosting 
factor, the quality and conformity of the SIB plans were 
observed to be dependent on the volume ratio PTV2/PTV1. 
For the analyzed patients, this ranged from 28.8% to 61.7%. 
For differences in the PTV1 to PTV2 volume larger than 40%, 
either a PTV2-3mm or the GTV itself were selected for the 
boosting. Else no gradient could be observed. When 
compared to the nominal sequential plan, the SIB approach 
resulted in both a lower mean dose to the ring area (average 
value for SIB: 55.2+1.0 GyRBE; average value for sequential: 
64.1+3.6 GyRBE), and 0.6+0.4% as average ring volume 
receiving the 95% of the dose prescribed to the boost (the 
same dose parameter was >10% for all the original plans). A 
similar sparing of OARs was obtained with both treatment 
schedules. 
Conclusion:  Planning H&N patients with SIB optimization 
resulted in dose distributions which guaranteed the PTV2 and 
PTV1 coverage and conformity whilst keeping dose to OARs 
within tolerance. Therefore this approach can be transferred 
to the clinical operation and has already been applied to a 
first patient.  
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Gamma locator is a handheld lightweight and compact 
gamma probe based on a scintillation crystal LaBr3:Ce and 
silicone photomultiplier to be used for detection of gamma-
radiation emitted by radionuclides such as 99mTc, 125I, 111In, 18F 
[1]. 
There are two main applications of gamma locator: 
intraoperative detection of sentinel lymph nodes and non-
invasive scanning the surface of the body. In the first case, a 
radiotracer is injected into the patient preoperatively and 
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surgeon checks the presence of metastasis in the lymph 
nodes after the removal of the tumor. In the second case, 
the gamma locator can detect tumors located superficially, 
and accurately determine their boundaries [2]. 
When selecting the scintillator the following requirements 
should be considered: high relative light yield compared to 
NaI(Tl), the high value of the effective atomic number. The 
lanthanum cerium bromine has demonstrated the best 
features: the light yield higher than that of NaI(Tl) (130%), 
high density, high atomic number provide high efficiency of 
photoelectric absorption of gamma rays, and the decay time 
of the order of tens of nanoseconds provides high temporal 
resolution of the detector. Silicon photomultiplier is a device 
for detection of low intensive and very fast (several hundred 
nanosecond duration) light flashes. SiPM is used due to its 
high detection efficiency, low bias voltage, compact 
dimensions and high gain of signals. Experimental studies 
have shown that a scintillator packaged together with the 
photodetector provides 4,1% FWHM energy resolution at 662 
keV (Cs-137). 
Gamma locator is constructed in cordless configuration and 
equipped with a lithium-ion battery. Indication is performed 
by an acoustic signal and LED. Adjusting of the bias voltage 
of the photodetector and the thresholds of the discriminator 
is carried out by changing the resistance of the trimmers.  
The main technical characteristics of the prototype gamma 
locator were determined in the laboratory of NRNU MEPhI 
according to the NEMA NU3-2004 protocol [3]. Spatial 
resolution of gamma locator is the minimum distance 
between two point sources on which they can be resolved 
separately, or FWHM of the dependence of counting rate of 
the transverse distance between the detector and the 
source, and is measured to be 20 mm. Spatial selectivity is 
the polar angle, at which the count rate drops twice and it is 
measured to be 26 degrees. Sensitivity is 118 cps/MBq.  
For the comparison performance of scintillation and 
semiconductor gamma locator the NEMA testing of the 
semiconductor CdTe-based commercial gamma probe was 
performed. The field of view of the CdTe gamma probe was 
formed with a lead collimator with 3 mm diameter aperture. 
Spatial resolution was measured to be 22 mm, and angular 
resolution is 30 degrees. 
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When treating tumors with radiotherapy, it is of utmost 
importance to ensure that the prescribed dose is accurately 
delivered to the target volumes. In that sense, in-vivo 
dosimetry in real time was recently implemented in 
radiotherapy departments. Dosimeter performance depends 
necessarily on physical and geometrical parameters (e.g. 
beam energy and distance from source to skin), which implies 
the use of correction factors. Implantable dosimeters are 
therefore preferable in order to minimize the need for 
corrections. They should be as small as possible, but still 
they should provide reliable measurements to comply with 
the requirements of clinical practice in routine radiotherapy. 
The state-of-the-art of these kind of dosimeters was the 
subject of a review elsewhere (1), which reported that 
implantable detectors of submillimetric size are currently 
available. The purpose of this study is to assess by Monte-
Carlo simulations how much the size of such dosimeters can 
be decreased without jeopardizing their performance in a 
clinical environment.  
First, the interaction of photons from a 60Co source with 
water was simulated with a Monte-Carlo tool (2). The 
calculations were performed for 0.3, 0.1, 1, 3 and 10 Gy. 
Then, the distributions of specific energy were obtained for 
volumes representing dosimeters at nanometric and 
micrometric scales. Cylinders with equal radii of 0.3, 0.1, 1, 
3 and 10 μm were used for this purpose. The mean specific 
energy <zt> was calculated for each case. To evaluate how 
the dosimeter size would impact its performance in a clinical 
scenario, the probability p that a dosimeter measurement 
falls outside a given interval defined around <zt> was 
estimated. Intervals were defined as [<zt>-γ<zt> ; <zt>+γ<zt>] 
with γ equal to 3%, 5% and 10%. 
The pattern of the distributions of specific energy evolves 
with dosimeter size and irradiation dose. Fixing the 
irradiation dose and decreasing the dosimeter radius or fixing 
the radius and decreasing the irradiation dose strongly 
widened the range in measured values of specific energy, but 
also increased the probability of yielding a non-null 
measurement. In turn, for higher doses and radii, 
distributions tend to Gaussian curves. 
 
Concerning the probability of obtaining a measurement 
outside the defined interval, the larger the interval, the 
irradiation dose, and the dosimeter radius, the smaller this 
probability became (see figure above). 
The simulation results showed that dosimeters at a 
nanometric scale are not able to yield statistically-
reproducible measurements and are therefore unfit for use in 
clinical practice. Increasing the size to micrometric scale led 
to a decrease in the statistical fluctuations. Nevertheless, to 
have enough accuracy at routine clinical doses 
(approximately 2 Gy in the tumor volume), a dosimeter 
radius of at least 10 μm is required. 
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